▶ 調査レポート

夜間頻尿 の世界市場

• 英文タイトル:Global Market Study on Nocturia: Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period

Persistence Market Researchが調査・発行した産業分析レポートです。夜間頻尿 の世界市場 / Global Market Study on Nocturia: Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period / B-PMR-063資料のイメージです。• レポートコード:B-PMR-063
• 出版社/出版日:Persistence Market Research / 2017年12月22日
• レポート形態:英文、PDF、192ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥509,600 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥790,400 (USD7,600)▷ お問い合わせ
  Corporate User¥1,102,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、夜間頻尿 の世界市場について調査・分析し、関連企業情報、産業分析、夜間頻尿 の世界市場規模、市場動向、セグメント別市場分析、地域別市場規模(欧州、アメリカ、アジアなど)、市場予測データを含め、以下の構成でお届けいたします。

Introduction
Nocturia is major problem in most of the population in different regions, as the condition for causing nocturia basically depends on ageing of the patient, incidences of chronic diseases such as diabetes or any other factors. Nocturia affects people of all age groups right from children to old people. In medical science, nocturia is known as excessive urination at night where the body produces more urine during sleep time. Nocturia affects the productivity of people suffering from the condition during working hours as well.

Persistence Market Research uses a unique research methodology which is a strong blend of secondary and in-depth primary research. Extensive primary interviews with key market players, stakeholders, market observers and experts are carried out to collect necessary data and information pertaining to various segments and across key regions. The data crunching and statistical analysis so performed undergoes multiple layers of validation to garner appropriate market insights which could benefit business by impacting critical decisions. The exhaustive research methodology has been applied to thoroughly understand and study the market for nocturia and the findings and insights have been skilfully crafted following a systematic structure in the new report titled “Nocturia Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026)”.

Global Nocturia Market: Segmentation

Market segmentation by indication

Based on indication, the market has been segmented into,

Mixed nocturia
Low nocturnal bladder capacity
Nocturnal polyuria
Global polyuria
Market segmentation by drug type

Based on drug type, the market has been segmented into,

Anticholinergic drugs
Desmopressin
Antibiotics
Antispasmodic
Others
Market segmentation by distribution channel

Based on Distribution Channel, the market has been segmented into,

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Market Segmentation by region

Based on region, the market is segmented into:

North America
Latin America
Europe
Asia Pacific excluding Japan
Japan
Middle East and Africa
The global nocturia market research study covers competitive landscape that includes market shares, revenues, growth strategies applied, product portfolio analysis, distribution channels, expansion in several geographies, marketing strategies, SWOT analysis, pricing analysis, etc., of the various key players in the global nocturia market. Such an intelligence framework can be used to gain competitive advantage in the long run, especially helpful for new entrants in the nocturia market.

Delivering value based insights backed by pertinent market data

In-depth market analysis, with scrutiny across important geographies
Weighted market segmentation to have a complete market understanding
Historical data, current statistics and a projected view of the market (forecasts) over a period of five years available in a well-structured format
Competitive landscape covering analyses on key players
Unbiased view of the global market drawing a realistic outline of data projections
Strong accurate research from a strategic standpoint to gain strategic advantage
Weighted analysis which covers each and every aspect of the global nocturia market

レポート目次

1. Global Outlook

2. Global Nocturia Market – Executive Summary

3. Global Nocturia Market Overview
3.1. Introduction
3.1.1. Global Nocturia Market Taxonomy
3.1.2. Global Nocturia Market Definition
3.2. Global Nocturia Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Nocturia Market Y-o-Y Growth
3.3. Global Nocturia Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Trends
3.4. Supply Chain
3.5. Cost Structure
3.6. Key Participants Market Presence (Intensity Map) By Region
3.7. Product Life Cycle Nocturia Market
3.8. List of Distributors
3.9. Key Regulations
3.9.1. U.S.
3.9.2. Canada
3.9.3. Europe

4. Global Nocturia Market Analysis and Forecast 2012-2026
4.1. Global Nocturia Market Size and Forecast By Indication, 2012-2026
4.1.1. Mixed Nocturia Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Low Nocturnal Bladder Capacity Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Nocturnal Polyuria Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Global Polyuria Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Nocturia Market Size and Forecast By Drug Type, 2012-2026
4.2.1. Anticholinergic Drugs Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Desmopressin Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Antibiotics Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Antispasmodic Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.2.5. Other Drugs Market Size and Forecast, 2012-2026
4.2.5.1. Revenue (US$ Mn) Comparison, By Region
4.2.5.2. Market Share Comparison, By Region
4.2.5.3. Y-o-Y growth Comparison, By Region
4.3. Global Nocturia Market Size and Forecast By Distribution Channel, 2012-2026
4.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Drug Stores Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Online Pharmacies Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Nocturia Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Indication
5.6. Revenue (US$ Mn) Comparison, By Drug Type
5.7. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Nocturia Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Indication
6.6. Revenue (US$ Mn) Comparison, By Drug Type
6.7. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Nocturia Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. U.K Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Indication
7.6. Revenue (US$ Mn) Comparison, By Drug Type
7.7. Revenue (US$ Mn) Comparison, By Distribution Channel

8. APEJ Nocturia Market Size and Forecast, 2012-2026
8.1. APEJ Outlook
8.2. APEJ Parent Market Outlook
8.3. APEJ Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
8.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
8.4.3. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.4.4. ASEAN Market Size and Forecast (US$ Mn), 2012-2026
8.4.5. Australia & New Zealand Market Size and Forecast (US$ Mn), 2012-2026
8.4.6. Rest of Asia Pacific Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Indication
8.6. Revenue (US$ Mn) Comparison, By Drug Type
8.7. Revenue (US$ Mn) Comparison, By Distribution Channel

9. MEA Nocturia Market Size and Forecast, 2012-2026
9.1. MEA Outlook
9.2. MEA Parent Market Outlook
9.3. MEA Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Indication
9.6. Revenue (US$ Mn) Comparison, By Drug Type
9.7. Revenue (US$ Mn) Comparison, By Distribution Channel

10. Global Nocturia Market Company Share, Competition Landscape and Company Profiles
10.1. Competition Landscape
10.2. Company Profiles
10.2.1. Allergan, Inc.
10.2.2. Urigen Pharmaceuticals
10.2.3. Ferring Pharmaceuticals
10.2.4. Glenmark Pharmaceuticals Inc.
10.2.5. Teva Pharmaceutical Industries Ltd.
10.2.6. AA Pharma Inc.
10.2.7. Avadel Pharmaceuticals plc

11. Research Methodology

12. Disclaimer

List of Tables

TABLE 1 Global Nocturia Market Value (US$ Mn), 2012-2017
TABLE 2 Global Nocturia Market Value (US$ Mn), 2018-2026
TABLE 3 Global Nocturia Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Mixed Nocturia Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Mixed Nocturia Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Mixed Nocturia Segment Market Share, By Region 2012-2017
TABLE 7 Global Mixed Nocturia Segment Market Share, By Region 2018-2026
TABLE 8 Global Mixed Nocturia Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2012-2017
TABLE 12 Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2018-2026
TABLE 13 Global Low Nocturnal Bladder Capacity Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Nocturnal Polyuria Segment Market Share, By Region 2012-2017
TABLE 17 Global Nocturnal Polyuria Segment Market Share, By Region 2018-2026
TABLE 18 Global Nocturnal Polyuria Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Polyuria Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Polyuria Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Polyuria Segment Market Share, By Region 2012-2017
TABLE 22 Global Polyuria Segment Market Share, By Region 2018-2026
TABLE 23 Global Polyuria Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Anticholinergic Drugs Segment Market Share, By Region 2012-2017
TABLE 27 Global Anticholinergic Drugs Segment Market Share, By Region 2018-2026
TABLE 28 Global Anticholinergic Drugs Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Desmopressin Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Desmopressin Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Desmopressin Segment Market Share, By Region 2012-2017
TABLE 32 Global Desmopressin Segment Market Share, By Region 2018-2026
TABLE 33 Global Desmopressin Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Antibiotics Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Antibiotics Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Antibiotics Segment Market Share, By Region 2012-2017
TABLE 37 Global Antibiotics Segment Market Share, By Region 2018-2026
TABLE 38 Global Antibiotics Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Antispasmodic Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Antispasmodic Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Antispasmodic Segment Market Share, By Region 2012-2017
TABLE 42 Global Antispasmodic Segment Market Share, By Region 2018-2026
TABLE 43 Global Antispasmodic Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Other Drugs Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Other Drugs Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Other Drugs Segment Market Share, By Region 2012-2017
TABLE 47 Global Other Drugs Segment Market Share, By Region 2018-2026
TABLE 48 Global Other Drugs Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 52 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 53 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 57 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 58 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Drug Stores Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Drug Stores Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Drug Stores Segment Market Share, By Region 2012-2017
TABLE 62 Global Drug Stores Segment Market Share, By Region 2018-2026
TABLE 63 Global Drug Stores Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 67 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 68 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 69 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 70 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 71 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 72 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 73 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 74 North America Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 75 North America Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 76 North America Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 77 North America Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 78 North America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 79 North America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 80 North America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 81 North America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 82 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 83 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 84 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 85 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 86 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 87 Latin America Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 88 Latin America Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 89 Latin America Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 90 Latin America Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 91 Latin America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 92 Latin America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 93 Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 94 Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 95 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 96 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 97 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 98 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 99 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 100 Europe Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 101 Europe Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 102 Europe Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 103 Europe Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 104 Europe Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 105 Europe Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 106 Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 107 Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 108 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 109 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 110 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 111 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 112 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 113 APEJ Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 114 APEJ Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 115 APEJ Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 116 APEJ Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 117 APEJ Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 118 APEJ Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 119 APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 120 APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 121 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 122 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 123 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 124 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 125 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 126 MEA Nocturia Market Value (US$ Mn), By Country 2012-2017
TABLE 127 MEA Nocturia Market Value (US$ Mn), By Country 2018-2026
TABLE 128 MEA Nocturia Market Value (US$ Mn), By Indication 2012-2017
TABLE 129 MEA Nocturia Market Value (US$ Mn), By Indication 2018-2026
TABLE 130 MEA Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 131 MEA Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 132 MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 133 MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026